Lexston Life Sciences Corp. (LEXT.CN)
CAD 0.19
(18.75%)
CAD 0.19
(18.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -674.71 Thousand CAD | 22.58% |
| 2022 | -871.53 Thousand CAD | 53.24% |
| 2021 | -1.86 Million CAD | -1657.47% |
| 2020 | -106.04 Thousand CAD | -1536.45% |
| 2019 | -6480.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -479.68 Thousand CAD | -324.33% |
| 2023 Q3 | -372.68 Thousand CAD | -169.71% |
| 2023 Q2 | -138.17 Thousand CAD | -22.91% |
| 2023 Q1 | -112.41 Thousand CAD | -100.3% |
| 2023 Q4 | -113.04 Thousand CAD | 69.67% |
| 2022 Q3 | -304.97 Thousand CAD | -443.39% |
| 2022 Q2 | -56.12 Thousand CAD | 80.59% |
| 2022 Q1 | -289.21 Thousand CAD | -289.23% |
| 2022 FY | -1.07 Million CAD | 42.38% |
| 2022 Q4 | -56.12 Thousand CAD | 81.6% |
| 2021 Q4 | 152.84 Thousand CAD | 142.9% |
| 2021 Q3 | -356.24 Thousand CAD | 45.69% |
| 2021 Q2 | -655.93 Thousand CAD | -22.75% |
| 2021 FY | -1.86 Million CAD | -1657.47% |
| 2021 Q1 | -534.37 Thousand CAD | 0.0% |
| 2020 Q3 | -241.83 Thousand CAD | -1395.6% |
| 2020 Q2 | -16.17 Thousand CAD | 0.0% |
| 2020 FY | -106.04 Thousand CAD | -1536.45% |
| 2019 FY | -6480.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 86.554% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 91.262% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 79.177% |
| BioVaxys Technology Corp. | -2.4 Million CAD | 71.917% |
| ChitogenX Inc. | -2.83 Million CAD | 76.158% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 81.954% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 94.669% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | -114.884% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 86.734% |
| Glow Lifetech Corp. | -1.64 Million CAD | 58.927% |
| Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | 11.565% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | -78.67% |
| MYND Life Sciences Inc. | -1.8 Million CAD | 62.677% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | 43.881% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 77.835% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | 29.945% |
| Telescope Innovations Corp. | -5.76 Million CAD | 88.3% |